Team:Lambert GA/safety

From 2013hs.igem.org

(Difference between revisions)
Line 57: Line 57:
The team was supervised by Mrs. Standeven, Dr. Styczynski, and Mrs. Cochran the entire time we were in the Georgia Tech lab.
The team was supervised by Mrs. Standeven, Dr. Styczynski, and Mrs. Cochran the entire time we were in the Georgia Tech lab.
-
====1. Would any of your project ideas raise safety issues in terms of:====
+
<h>====1. Would any of your project ideas raise safety issues in terms of:====</h>
*researcher safety,  
*researcher safety,  
*public safety, or  
*public safety, or  
Line 73: Line 73:
----
----
-
====2. Do any of the new BioBrick parts (or devices) that you made this year raise safety issues? ====
+
<h>====2. Do any of the new BioBrick parts (or devices) that you made this year raise safety issues? ==== </h>
Line 84: Line 84:
----
----
-
====3. Is there a local biosafety group, committee, or review board at your institution? ====
+
<h>====3. Is there a local biosafety group, committee, or review board at your institution? ==== </h>
*If yes, what does your local biosafety group think about your project?  
*If yes, what does your local biosafety group think about your project?  
*If no, which specific biosafety rules or guidelines do you have to consider in your country?
*If no, which specific biosafety rules or guidelines do you have to consider in your country?
Line 99: Line 99:
----
----
-
====4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering? ====
+
<h>====4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering? ==== </h>
=====Guidance:=====   
=====Guidance:=====   
This is an open-ended space for you to consider and suggest ways of improving safety or safety awareness at iGEM and beyond.  Some iGEM teams have offered ideas (and sometimes full projects) to limit gene flow, to create software for screening pathogens, and to reduce reliance on antibiotic resistant markers.  Other iGEM projects have discussed concerns that might arise if the project succeeded and became widely used, as commercial product or other means of distribution.  Some iGEM projects have discussed risks that might materialize if the knowledge generated or methods developed were to become more widely available.
This is an open-ended space for you to consider and suggest ways of improving safety or safety awareness at iGEM and beyond.  Some iGEM teams have offered ideas (and sometimes full projects) to limit gene flow, to create software for screening pathogens, and to reduce reliance on antibiotic resistant markers.  Other iGEM projects have discussed concerns that might arise if the project succeeded and became widely used, as commercial product or other means of distribution.  Some iGEM projects have discussed risks that might materialize if the knowledge generated or methods developed were to become more widely available.

Revision as of 17:32, 12 June 2013